Ketoconazole/MetyraponeHepatotoxicity and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2032卷 / 1期

关键词：

D O I：

10.1007/s40278-024-69889-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：228 / 228

相关论文

共 50 条

[1] RituximabHypogammaglobulinaemia and off-label use: case report
Reactions Weekly, 2023, 1956 (1) : 453 - 453
[2] PosaconazoleHepatotoxicity and off-label use: case report
Reactions Weekly, 2024, 2021 (1) : 447 - 447
[3] PasireotideHyperglycaemia and off-label use: case report
Reactions Weekly, 2021, 1876 (1) : 273 - 273
[4] RituximabCellulitis and off-label use: case report
Reactions Weekly, 2022, 1911 (1) : 363 - 363
[5] IbrutinibNeutropenia and off-label use: case report
Reactions Weekly, 2020, 1787 (1) : 271 - 271
[6] AntineoplasticsPancytopenia and off-label use: case report
Reactions Weekly, 2020, 1825 (1) : 39 - 39
[7] DexmedetomidineHypotension and off-label use: case report
Reactions Weekly, 2019, 1749 (1) : 172 - 172
[8] AzithromycinCardiotoxicity and Off-label use: case report
Reactions Weekly, 2023, 1953 (1) : 100 - 100
[9] LinezolidLeukopenia and off-label use: case report
Reactions Weekly, 2025, 2044 (1) : 180 - 180
[10] MirtazapineOtotoxicity and off-label use: case report
Reactions Weekly, 2024, 2037 (1) : 255 - 255

← 1 2 3 4 5 →